Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGTI
3401
DELISTED
PGT, Inc.
PGTI
| $1.24M | ﹤0.01% |
71,765
+5,903
| +9% | +$92.8K |
|
|
STG
3402
Sunlands Technology
STG
$47M
| $1.24M | ﹤0.01% |
33,600
| – | – |
|
3403
Kemper
KMPR
$1.72B
| $1.24M | ﹤0.01% |
15,837
-106,163
| -87% | -$8.48M |
|
3404
Cal-Maine
CALM
$4B
| $1.23M | ﹤0.01% |
30,838
-51,584
| -63% | -$2.14M |
|
3405
PUT
iShares Russell 2000 Growth ETF
IWO
$15B
| $1.23M | ﹤0.01% |
6,400
+1,700
| +36% | +$337K |
|
3406
PUT
Edwards Lifesciences
EW
$51.6B
| $1.23M | ﹤0.01% |
16,800
-15,600
| -48% | -$1.1M |
|
3407
OFG Bancorp
OFG
$2.21B
| $1.23M | ﹤0.01% |
56,179
-9,949
| -15% | -$219K |
|
|
ARGO
3408
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.23M | ﹤0.01% |
17,457
-9,551
| -35% | -$660K |
|
3409
CALL
AGNC Investment
AGNC
$12.9B
| $1.23M | ﹤0.01% |
76,200
+59,100
| +346% | +$970K |
|
3410
CALL
Zillow
ZG
$7.55B
| $1.23M | ﹤0.01% |
41,500
-25,100
| -38% | -$995K |
|
3411
CALL
Cheesecake Factory
CAKE
$5.31B
| $1.23M | ﹤0.01% |
29,400
+28,800
| +4,800% | +$1.18M |
|
|
INXN
3412
DELISTED
Interxion Holding N.V.
INXN
| $1.23M | ﹤0.01% |
15,034
-1,432
| -9% | -$111K |
|
3413
Insmed
INSM
$27.7B
| $1.22M | ﹤0.01% |
69,331
+12,119
| +21% | +$234K |
|
|
EMWP
3414
DELISTED
Eros Media World PLC
EMWP
| $1.22M | ﹤0.01% |
31,814
-6,076
| -16% | -$216K |
|
3415
IMAX
IMAX
$2.72B
| $1.21M | ﹤0.01% |
55,276
+6,106
| +12% | +$130K |
|
|
3416
CALL
iShares Russell 2000 Growth ETF
IWO
$15B
| $1.21M | ﹤0.01% |
6,300
-200
| -3% | -$39.7K |
|
|
ZUO
3417
DELISTED
Zuora, Inc.
ZUO
| $1.21M | ﹤0.01% |
80,654
-22,735
| -22% | -$342K |
|
3418
CVR Energy
CVI
$3.17B
| $1.21M | ﹤0.01% |
27,538
-14,246
| -34% | -$663K |
|
3419
PUT
Danaher
DHR
$142B
| $1.21M | ﹤0.01% |
9,475
+338
| +4% | +$42.3K |
|
3420
CALL
Stanley Black & Decker
SWK
$15.6B
| $1.21M | ﹤0.01% |
8,400
-19,500
| -70% | -$2.75M |
|
|
DNR
3421
DELISTED
Denbury Resources, Inc.
DNR
| $1.21M | ﹤0.01% |
1,018,053
-679,533
| -40% | -$784K |
|
|
AIMT
3422
DELISTED
Aimmune Therapeutics
AIMT
| $1.21M | ﹤0.01% |
57,926
+19,026
| +49% | +$388K |
|
|
CLVS
3423
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.21M | ﹤0.01% |
307,700
+275,200
| +847% | +$2.23M |
|
3424
Healthcare Services Group
HCSG
$1.54B
| $1.21M | ﹤0.01% |
49,712
-22,134
| -31% | -$559K |
|
|
CRON
3425
PUT
Cronos Group
CRON
$1.16B
| $1.21M | ﹤0.01% |
133,300
-96,700
| -42% | -$1.24M |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.